| ID | Name | CAS | Properties |
MW (g/mol) |
| 62-052-5 |
Silane, diethyl(3,4-dimethylphenoxy)octadecyloxy-
|
|
2 | 476.85 |
| 62-405-3 |
Silane, dimethyl(2,5-dichlorophenyloxy)isohexyloxy-
|
|
2 | 321.31 |
| 62-469-3 |
Naphthoresorcinol, O,O'-di(tert.-butyldimethylsilyl)-
|
|
2 | 388.69 |
| 62-563-8 |
Benzenesulfonic acid, p-chloro-,sodium salt
|
|
2 | 214.60 |
| 62-568-3 |
16,17-dihydro-GA34, Me-TMS
|
|
2 | 508.80 |
| 62-569-2 |
5-(Methylthio)salicylic acid, trimethylsilyl ester
|
|
2 | 256.39 |
| 62-773-5 |
Creatinine, N,N'-di(tert.-butyldimethylsilyl)-
|
|
2 | 341.65 |
| 62-801-3 |
Silane, diethylethoxy(2-methylpent-3-yloxy)-
|
|
2 | 232.44 |
| 62-886-0 |
2-C-Methylerythronic acid, tris-TMS
|
|
2 | 438.86 |
| 62-985-0 |
3-Methyl-3-butenyl caffeate, TMS
|
|
2 | 392.64 |
| 63-035-3 |
Uracil, 1,3-diethyl-5-fluoro-
|
|
2 | 186.19 |
| 63-125-3 |
Butyro-1,4-lactam, mono-TMS
|
|
2 | 157.29 |
| 63-198-3 |
Silane, diphenylheptyloxy(2,4,4-trimethylpentyloxy)-
|
|
2 | 426.72 |
| 63-211-7 |
Silanol, trimethyl-, triester with arsenic acid
|
17921-76-5 |
2 | 358.49 |
| 63-302-6 |
«beta»-L(+)-Rhamnose, pyranose, TMS
|
|
2 | 452.88 |
| 63-426-9 |
(2-Fluorophenyl)methanol, tert-butyldimethylsilyl ether
|
|
2 | 240.39 |
| 63-687-0 |
Silane, dimethyl(2,3-dimethylphenoxy)hexyloxy-
|
|
2 | 280.48 |
| 63-806-7 |
1-(2,4,6-Trisopropylbenzenesulfonyl)imidazole
|
50257-40-4 |
2 | 334.48 |
| 63-830-0 |
PGE2, BO-TMS, isomer # 1
|
|
2 | 640.14 |
| 63-976-9 |
Silane, diphenylisobutoxy(2,3,4-trifluorophenoxy)-
|
|
2 | 402.48 |
| 64-040-6 |
(R)-2-butyl-L-Glc, TMS
|
|
2 | 524.99 |
| 64-127-0 |
24-Ethyl-.delta.(22)-coprostenol, tms
|
|
2 | 486.90 |
| 64-308-9 |
Lumazine, 6,7-dimethyl- (keto form)
|
5774-32-3 |
2 | 192.17 |
| 64-412-3 |
Benzoic acid, 3-trifluoroacetylthio-, trimethylsilyl ester
|
|
2 | 322.38 |
| 64-442-0 |
Purine-6(1h)-one, 1-benzyl-
|
|
2 | 226.24 |
| 64-480-8 |
Thromboxane B2, 9,12-methaneboronate-TMS
|
|
2 | 394.31 |
| 64-682-4 |
Silane, diphenylisobutoxy(5-methoxy-3-methylpentyloxy)-
|
|
2 | 386.61 |
| 64-695-0 |
Estran-4-on-17B-ol, TMS
|
|
2 | 420.79 |
| 64-963-2 |
Silane, diethyl(2,5-dimethylphenoxy)nonyloxy-
|
|
2 | 350.61 |
| 64-999-3 |
Silane, diethyloctyloxy(2,3,6-trichlorophenoxy)-
|
|
2 | 411.87 |
| 65-007-2 |
Silane, diphenyl(3,4-dimethylcyclohexyloxy)isohexyloxy-
|
|
2 | 410.66 |
| 65-111-6 |
Silane, dimethyl(3,5-dichlorophenoxy)dimethylamino-
|
|
2 | 264.22 |
| 65-116-1 |
Arabinonic acid, «gamma»-lactone, tris-TMS
|
|
2 | 364.66 |
| 65-222-3 |
«alpha»-D(+)-Galactose, pyranose, TMS
|
|
2 | 527.03 |
| 65-257-5 |
«beta»-D-Allopyranose, pentakis(trimethylsilyl) ether
|
|
2 | 541.06 |
| 65-363-7 |
2-C-Methylarabinonic acid, pentakis-TMS
|
|
2 | 541.06 |
| 65-552-7 |
L-HYDROXYPROLINE,N,O,O-TMS
|
|
2 | 347.67 |
| 65-891-1 |
2-Methyl-1-dimethyl(pentafluorophenyl)silyloxypropane
|
71338-75-5 |
2 | 298.32 |
| 65-953-2 |
1-(4-Bromophenyl)imidazoline-2-thione
|
|
2 | 255.14 |
| 66-111-5 |
7-«beta»,12-«beta»-Dihydroxykaurenolide, TMS
|
|
2 | 476.80 |
| 66-115-1 |
2-(P-methoxyanilino)-3-methyl pyrazine
|
|
2 | 215.26 |
| 66-129-6 |
Glycine, N-(2-methylbutanoyl), bis-TMS
|
|
2 | 303.55 |
| 66-151-1 |
Ethanone, 1-(1H-pyrazol-4-yl)-
|
|
2 | 110.12 |
| 66-212-3 |
Methyl 2-isothiocyanato-4-(methylthio)butyrate
|
21055-47-0 |
2 | 205.30 |
| 66-319-5 |
Purine-6(3h)-one, 3-benzyl-
|
|
2 | 226.24 |
| 66-416-7 |
threonine, N(O,S)-isoBOC TBDMS
|
|
2 | 433.62 |
| 66-480-6 |
Silane, diethyl(3,4-dimethylphenoxy)pentadecyloxy-
|
|
2 | 434.77 |
| 66-511-1 |
«beta»-D(+)-Fucose, pyranose, TMS
|
|
2 | 527.03 |
| 66-514-8 |
«beta»-D(+)-Mannose, pyranose, TMS
|
|
2 | 527.03 |
| 66-515-7 |
«alpha»-D(+)-Mannose, pyranose, TMS
|
|
2 | 527.03 |
| 66-516-6 |
«alpha»-D(+)-Talose, pyranose, TMS
|
|
2 | 527.03 |
| 66-593-1 |
Gluconic acid lactone, TMS # 1
|
|
2 | 466.86 |
| 66-622-8 |
Deoxyribopyranose, tris(trimethylsilyl) ether (isomer 2)
|
|
2 | 350.67 |
| 66-686-8 |
Silane, diethylpentyloxy(2,4,5-trichlorophenoxy)-
|
|
2 | 369.79 |
| 66-751-5 |
3-Chloro-1-cyclohexyldimethylsilyloxyprop-2-ene
|
|
2 | 232.82 |
| 66-849-7 |
[14C] GA31 methyl ester TMS ether
|
|
2 | 416.58 |
| 66-964-9 |
PGA1, EO-TMS, isomer # 1
|
|
2 | 523.90 |
| 67-018-8 |
4-Deoxytetronic acid, threo-, tri-TMS
|
|
2 | 336.65 |
| 67-048-5 |
Inositol, isomer # 2, hexakis-TMS
|
|
2 | 613.24 |
| 67-219-5 |
Silane, diethyl(3,4-dimethylphenoxy)undecyloxy-
|
|
2 | 378.66 |
| 67-564-2 |
(+)-«alpha»-Tocopherol, O-tert.-butyldimethylsilyl-
|
|
2 | 544.97 |
| 67-908-0 |
propyl-cannabinolic acid, n-butyl-boronate
|
|
2 | 392.30 |
| 67-923-3 |
Silane, diethyloctyloxy(2,4,5-trichlorophenoxy)-
|
|
2 | 411.87 |
| 68-071-8 |
Tryptophan, N-acetyl-5-methoxy, TMS
|
|
2 | 420.65 |
| 68-199-7 |
5-Amino-6-chloro-4-ethylaminopyrimidine
|
|
2 | 172.62 |
| 68-366-1 |
PGD1, BO-TMS, isomer # 1
|
|
2 | 642.15 |
| 68-441-7 |
9H-Purine, 6-chloro-9-(methoxymethyl)-
|
|
2 | 198.61 |
| 68-494-9 |
GA7-isolactone, methyl ester TMS ether
|
|
2 | 418.60 |
| 68-597-5 |
Xylonic acid, 1,4-lactone, TMS
|
|
2 | 364.66 |
| 68-623-5 |
2,6-Dimethylbenzenethiol, S-(tert-butyldimethylsilyl)-
|
|
2 | 252.49 |
| 68-654-1 |
Deoxyribopyranose, tris(trimethylsilyl) ether (isomer 1)
|
|
2 | 350.67 |
| 68-763-0 |
2-Butanol, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 199.37 |
| 68-795-5 |
4,4'-Methylenebis(3-chlorophenyl)diisothiocyanate
|
|
2 | 351.28 |
| 68-798-2 |
cis-Acenaphthen-1,2-diol, butylboronate
|
|
2 | 252.12 |
| 68-902-5 |
9H-purine, 6-mercapto-, 8-ethyl-
|
101861-17-0 |
2 | 180.23 |
| 69-037-5 |
PGD1, BO-TMS, isomer # 2
|
|
2 | 642.15 |
| 69-129-3 |
Silane, diphenyl(cis-4-methylcyclohexyloxy)undecyloxy-
|
|
2 | 466.77 |
| 69-327-3 |
«beta»-D-(-)-Ribopyranose, tetrakis(trimethylsilyl) ether
|
|
2 | 438.85 |
| 69-340-8 |
1-Cyclopentylethanol, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 239.44 |
| 69-355-2 |
1-(1-phenylcyclohexyl)-3-hydroxypiperidine (TMS)
|
|
2 | 331.57 |
| 69-568-6 |
Fluoxymesterone, tris-TMS (2,4-diene)
|
|
2 | 553.00 |
| 69-638-8 |
GA53-aldhyde methyl ester TMS ether
|
|
2 | 462.65 |
| 69-676-6 |
[13C] GA58 methyl ester TMS ether
|
|
2 | 506.78 |
| 69-677-5 |
allo-Tetrahydrocorticosterone, MO-TMS # 2
|
|
2 | 596.08 |
| 69-705-3 |
[14C1]GA60 methyl ester TMS ether
|
|
2 | 506.78 |
| 69-711-6 |
[14C1]GA1 methyl ester TMS ether
|
|
2 | 506.79 |
| 69-808-9 |
DL-Arabinose, tetrakis(trimethylsilyl) ether, methyloxime
|
|
2 | 467.90 |
| 70-202-9 |
allo-Tetrahydrocorticosterone, TMSO-TMS # 2
|
|
2 | 654.23 |
| 70-225-4 |
GA122 (1,2-didehydro GA69), MeTMS
|
|
2 | 416.58 |
| 70-277-7 |
Arabinonic acid, 1,4-lactone, TMS
|
74742-31-7 |
2 | 364.66 |
| 70-367-7 |
GLUCO-GULO-HEPTOSE MEOX 6TMS-1
|
|
2 | 672.31 |
| 70-370-3 |
D-glucuronic acid, TMS diethyldithioacetal derivative
|
|
2 | 661.30 |
| 70-588-2 |
Threono-1,4-lactone, di-TMS
|
|
2 | 262.45 |
| 70-614-2 |
allo-Tetrahydrocorticosterone, EO-TMS # 2
|
|
2 | 610.10 |
| 70-615-1 |
allo-Tetrahydrocorticosterone, EO-TMS # 1
|
|
2 | 610.10 |
| 70-706-0 |
[14C] GA17 methyl ester TMS ether
|
|
2 | 492.68 |
| 70-748-4 |
Thromboxane B2, MO-tris-TMS, major
|
|
2 | 616.06 |
| 70-749-3 |
PGA2, MO-TMS, isomer # 2
|
|
2 | 507.86 |
| 70-844-7 |
sec-Butyl methylphosphonofluoridate, diastereomer # 1
|
|
2 | 154.12 |
| 70-959-0 |
PGE2, BO-TMS, isomer # 2
|
|
2 | 640.14 |
|
« Previous Results
Next Results »
|